Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Bariatric Surgery

NCT02607488 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

180

Enrollment

OTHER

Sponsor class

Stopped No fund no enough recruiting centers

Conditions

Obesity
Bariatric Surgery Candidate

Interventions

DRUG: Placebo
DRUG: Lidocaine 1%
DRUG: Lidocaine 1.5%
DRUG: Lidocaine 2%

Sponsor

Mansoura University